The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Specialty Generics Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Specialty Generics market size in 2023 is 80764.1 million US dollars, and it is expected to be 144818.9 million US dollars by 2030, with a compound annual growth rate of 8.7% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Specialty Generics market include Teva Pharmaceuticals Industries Ltd., Viatris Inc., Novartis AG, Hikma Pharmaceuticals PLC, and Mallinckrodt; Akorn, Inc.. The share of the top 3 players in the Specialty Generics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Specialty Generics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Injectables accounted for XX% of Specialty Generics market in 2023. Oral Drugs share of XX%.
Specialty Pharmacy accounted for XX% of the Specialty Generics market in 2023. Retail Pharmacy accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Specialty Generics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Specialty Generics market country revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Specialty Generics market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Specialty Generics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Specialty Generics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
Teva Pharmaceuticals Industries Ltd.
Viatris Inc.
Novartis AG
Hikma Pharmaceuticals PLC
Mallinckrodt; Akorn, Inc.
Bausch Health Companies Inc.
Reddy’s Laboratories Ltd.
Endo Pharmaceuticals Inc.
Apotex Corp.
Sun Pharmaceutical Industries Ltd.
Types list
Injectables
Oral Drugs
Application list
Specialty Pharmacy
Retail Pharmacy
List of Tables and Figures
Figure Specialty Generics Picture
Table Product Definition of Specialty Generics
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Specialty Generics Market Size by Type (2019 VS 2024 VS 2030)
Table Global Specialty Generics Revenue by Type (2019-2024)
Table Global Specialty Generics Revenue and Share by Type (2019-2024)
Table Global Specialty Generics Market Size by Application (2019 VS 2024 VS 2030)
Table Global Specialty Generics Revenue by Application (2019-2024)
Table Global Specialty Generics Revenue Share by Application (2019-2024)
Figure Global Specialty Generics Revenue Market Size Growth (2019-2024)
Table Specialty Generics Market Size by Regions: 2019 VS 2024 VS 2030
Table Specialty Generics Revenue Market Size by Regions (2019-2024)
Table Specialty Generics Revenue and Share by Regions (2019-2024)
Figure North America Specialty Generics Market Size (2019-2024)
Figure Europe Specialty Generics Market Size (2019-2024)
Figure Asia-Pacific Specialty Generics Market Size (2019-2024)
Figure Latin America Specialty Generics Market Size (2019-2024)
Figure Middle East & Africa Specialty Generics Market Size (2019-2024)
Table North America Specialty Generics Revenue by Countries (2019-2024)
Table North America Specialty Generics Revenue and Share by Countries (2019-2024)
Table North America PEST Analysis
Figure United States Specialty Generics Revenue and Growth (2019-2024)
Figure Canada Specialty Generics Revenue and Growth (2019-2024)
Figure Canada Specialty Generics Sales and Growth (2019-2024)
Table Asia-Pacific Specialty Generics Revenue by Countries (2019-2024)
Table Asia-Pacific Specialty Generics Revenue and Share by Countries (2019-2024)
Table Asia-Pacific PEST Analysis
Figure China Specialty Generics Revenue and Growth (2019-2024)
Figure Japan Specialty Generics Revenue and Growth (2019-2024)
Figure Korea Specialty Generics Revenue and Growth (2019-2024)
Figure Southeast Asia Specialty Generics Revenue and Growth (2019-2024)
Figure India Specialty Generics Revenue and Growth (2019-2024)
Figure Australia Specialty Generics Revenue and Growth (2019-2024)
Table Europe Specialty Generics Revenue by Countries (2019-2024)
Table Europe Specialty Generics Revenue and Share by Countries (2019-2024)
Table Europe PEST Analysis
Figure Germany Specialty Generics Revenue and Growth (2019-2024)
Figure France Specialty Generics Revenue and Growth (2019-2024)
Figure UK Specialty Generics Revenue and Growth (2019-2024)
Figure Italy Specialty Generics Revenue and Growth (2019-2024)
Figure Russia Specialty Generics Revenue and Growth (2019-2024)
Figure Spain Specialty Generics Revenue and Growth (2019-2024)
Figure Nordic Specialty Generics Revenue and Growth (2019-2024)
Table Latin America Specialty Generics Revenue by Countries (2019-2024)
Table Latin America Specialty Generics Revenue and Share by Countries (2019-2024)
Table Latin America PEST Analysis
Figure Brazil Specialty Generics Revenue and Growth (2019-2024)
Figure Argentina Specialty Generics Revenue and Growth (2019-2024)
Figure Mexico Specialty Generics Revenue and Growth (2019-2024)
Table Middle East & Africa Specialty Generics Revenue by Countries (2019-2024)
Table Middle East & Africa Specialty Generics Revenue and Share by Countries (2019-2024)
Table Middle East & Africa PEST Analysis
Figure Egypt Specialty Generics Revenue and Growth (2019-2024)
Figure South Africa Specialty Generics Revenue and Growth (2019-2024)
Figure UAE Specialty Generics Revenue and Growth (2019-2024)
Figure Turkey Specialty Generics Revenue and Growth (2019-2024)
Figure Saudi Arabia Specialty Generics Revenue and Growth (2019-2024)
Table Global Specialty Generics Revenue by Players (2019-2024)
Table Global Specialty Generics Revenue Market Share by Players (2019-2024)
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Specialty Generics Players Market Concentration Ratio (CR5) (2019-2024)
Table Specialty Generics Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Teva Pharmaceuticals Industries Ltd. Profile
Table Product Overview
Table Teva Pharmaceuticals Industries Ltd. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Teva Pharmaceuticals Industries Ltd. Revenue and Growth Rate
Figure Teva Pharmaceuticals Industries Ltd. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Viatris Inc. Profile
Table Product Overview
Table Viatris Inc. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Viatris Inc. Revenue and Growth Rate
Figure Viatris Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Novartis AG Profile
Table Product Overview
Table Novartis AG Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Hikma Pharmaceuticals PLC Profile
Table Product Overview
Table Hikma Pharmaceuticals PLC Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Hikma Pharmaceuticals PLC Revenue and Growth Rate
Figure Hikma Pharmaceuticals PLC Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Mallinckrodt; Akorn, Inc. Profile
Table Product Overview
Table Mallinckrodt; Akorn, Inc. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Mallinckrodt; Akorn, Inc. Revenue and Growth Rate
Figure Mallinckrodt; Akorn, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Bausch Health Companies Inc. Profile
Table Product Overview
Table Bausch Health Companies Inc. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Bausch Health Companies Inc. Revenue and Growth Rate
Figure Bausch Health Companies Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Reddy’s Laboratories Ltd. Profile
Table Product Overview
Table Reddy’s Laboratories Ltd. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Reddy’s Laboratories Ltd. Revenue and Growth Rate
Figure Reddy’s Laboratories Ltd. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Endo Pharmaceuticals Inc. Profile
Table Product Overview
Table Endo Pharmaceuticals Inc. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Endo Pharmaceuticals Inc. Revenue and Growth Rate
Figure Endo Pharmaceuticals Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Apotex Corp. Profile
Table Product Overview
Table Apotex Corp. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Apotex Corp. Revenue and Growth Rate
Figure Apotex Corp. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Sun Pharmaceutical Industries Ltd. Profile
Table Product Overview
Table Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue, Gross and Gross Margin (2019-2024)
Figure Sun Pharmaceutical Industries Ltd. Revenue and Growth Rate
Figure Sun Pharmaceutical Industries Ltd. Revenue Market Share 2017-2023
Table Business Overview
Table Recent Developments and Plans
Table Global Specialty Generics Revenue Forecast by Type (2024-2030)
Table Global Specialty Generics Revenue and Share Forecast by Type (2024-2030)
Table Global Specialty Generics Revenue by Application (2024-2030)
Table Global Specialty Generics Revenue and Share by Application (2024-2030)
Figure Global Specialty Generics Revenue Forecast Market Size (2024-2030)
Table Specialty Generics Revenue Forecast by Regions (2024-2030)
Table Specialty Generics Revenue and Share Forecast by Regions (2024-2030)
Figure North America Specialty Generics Revenue Forecast Market Size (2024-2030)
Figure Europe Specialty Generics Revenue Forecast Market Size (2024-2030)
Figure Asia-Pacific Specialty Generics Revenue Forecast Market Size (2024-2030)
Figure Latin America Specialty Generics Revenue Forecast Market Size (2024-2030)
Figure Middle East & Africa Specialty Generics Revenue Forecast Market Size (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
